Marimed (MRMD) Income from Continuing Operations (2011 - 2026)

Marimed (MRMD) has 16 years of Income from Continuing Operations data on file, last reported at 3767000.0 in Q1 2026.

• On a quarterly basis, Income from Continuing Operations rose 31.25% year-over-year to 3767000.0 in Q1 2026; TTM through Mar 2026 was 12619000.0, a 22.92% increase from a year earlier, with the FY2025 full-year figure at 14456000.0, down 16.3% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 3767000.0, up from 4641000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for MRMD reached as high as 4749000.0 in Q4 2022 and fell as low as 10139000.0 in Q4 2023.
• Historically, Income from Continuing Operations has averaged 1922470.59 across 5 years, with a median of 1292000.0 in 2024.
• Across the five-year window, Income from Continuing Operations soared 174.13% in 2022 and slumped 324.07% in 2025, its largest moves.
• Year by year, Income from Continuing Operations stood at 4749000.0 in 2022, then plunged by 313.5% to 10139000.0 in 2023, then gained by 18.49% to 8264000.0 in 2024, then soared by 43.84% to 4641000.0 in 2025, then increased by 18.83% to 3767000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 3767000.0 in Q1 2026, 4641000.0 in Q4 2025, and 2941000.0 in Q3 2025.